Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
Acta Pharmaceutica Sinica B(2022)
Abstract
The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery.Image 1
MoreTranslated text
Key words
SARS-CoV-2,Delta variant,Heparan sulfate,Spike protein,Heparin nanoparticle,Pulmonary delivery
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined